Publications by authors named "Lucie Fayette"

Claim this Profile
U
Using Fisher Information Matrix to predict uncertainty in covariate effects and power to detect their relevance in Non-Linear Mixed Effect Models in pharmacometrics.
Lucie Fayette, Karl Brendel, France Mentré

J Pharmacokinet Pharmacodyn· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Impact of Multiple Imputation Algorithms on Pharmacokinetic Model Performance: A Simulation-Based Study.
Thomas Duflot, Lucie Fayette, Céline Konecki, Jérémy Seurat, Catherine Feliu

AAPS J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.
Mélanie Guhl, Julie Bertrand, Lucie Fayette, François Mercier, Emmanuelle Comets

AAPS J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.
Mélanie Guhl, Julie Bertrand, Lucie Fayette, François Mercier, Emmanuelle Comets

AAPS J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes.
Lucie Fayette, Martin Oliver Sailer, Alejandro Perez-Pitarch

CPT Pharmacometrics Syst Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust and Adaptive Two-stage Designs in Nonlinear Mixed Effect Models.
Lucie Fayette, Romain Leroux, France Mentré, Jérémy Seurat

AAPS J· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records.
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Rada Savic, Cécile Goujard

Antimicrob Agents Chemother· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis